“…The aim of this work was to develop the catalytic or stoichiometric reduction of ester group in 5-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-7-(morpholin-4-yl) pyrazolopyrimidine-2-carboxylate (1) to the corresponding primary alcohol, {5-[2-(difluoromethyl)-1H-1,3-benzodiazol-1-yl]-7-(morpholin-4-yl)pyrazolo [1,5-a]pyrimidin-2-yl}methanol (2), in a continuous flow process in order to combine it in a telescoped sequence with Pd-catalyzed flow oxidation of 2 to aldehyde 3. 12 The hydrogenation of ester group in substrate 1 itself is quite a demanding transformation, which may lead to multiple products: the substrate with the hydrogenated benzimidazole ring (1b) (Table 1), the desired alcohol with a double bond in the benzimidazole ring (2), and alcohol with a reduced double bond in the benzimidazole ring (2b). However, in the next step of CPL302415 synthesis, we can recover the double bond in the benzimidazole ring, 12 which is very important for CPL302415 stability, but the 2b alcohol is much less soluble than 2.…”